undamentalytics Newsletter
Sign in

Healthcare Services Group Inc (HCSG) stock

Add to watchlist

Add holding +

NASDAQ: HCSG Nasdaq Diversified Support Services Next results ~February 10, 2027

C+ Fundamentals grade

Healthcare Services Group Inc is a US-listed company in the diversified support services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$31

Cash-flow model

Base case. Range ~$24–$41 across our lower- and higher-growth cases (-1%–9% a year).

Price vs value

Modestly undervalued

The price is inside our value range, 18% below our base value.

Price used: $25.76, November 2, 2026

Healthcare Services Group Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 5 selling0 purchases and 8 sales by directors and officers, last 12 monthsInsider trades
  • Funds137 adding, 133 cuttingOf 45 active managers that changed their stake, 23 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Healthcare Services Group files

Where Healthcare Services stands after its latest 10-Q

Revenue for the twelve months to September 2026 was $1.88bn, up 4.0% on a year earlier, slower than the 5.2% growth a quarter earlier. Free-cash-flow margin fell to 5.7% from 8.7% a year earlier. The diluted share count is down 4.0% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 1 of our 1 financial-health checks. Our cash-flow model value is $27.74 a share, against a share price of $25.16. At that price, our model says the market is pricing in about 2.1% a year of cash-flow growth for five years, close to the 2.7% a year revenue growth it has delivered.

Source: 10-Q filed October 23, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 10, 2027 (estimated)

Healthcare Services Group Inc's trailing-twelve-month revenue grew 4.0% year on year, with a free-cash-flow margin of 5.7%. Where it stands out: stock pay as % of revenue of 0.6% ranks 6 of 26 diversified support services companies we cover.

Our discounted-cash-flow model values the business at ~$31 per share in the base case (~$24–$41 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 32.4% while net income grew 163.9%: a 196pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Priced below our value. The share price of $25.76 is 21% below our value per share of $31.
  • Shrinking share count. Diluted shares fell 4.0% in a year, so each share owns more of the business.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Earnings expected to fall. The consensus expects earnings per share to fall 5% next year.

Latest results: FY2026 Q3

Filed October 23, 2026
Earnings per share
$0.36 against an average estimate of $0.24: beat by 50.9%
Revenue
$480m, up 3.3% on a year earlier
Share reaction
+15.3% in the first session after the results on October 21, 2026, against -0.7% for the S&P 500
Guidance given
fourth quarter revenue $535m to $545m (fourth quarter); full-year effective tax rate 25% (full-year)
Next report
October 21, 2026; average EPS estimate $0.26

Healthcare Services Group's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+5.1%
  • 1 week+2.5%
  • 1 month+23.4%
  • This year+34.7%
  • 1 year+44.2%
  • 5 years+41.5%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$1.9B
Net margin
5.6%
EPS (TTM, diluted)
$1.49

Growth

Revenue growth
+4.0%
Change in growth rate
−1.3 pts
Share count change
−4.0%

Cash

Free cash flow (TTM)
$107M
FCF margin
5.7%
Stock pay % of revenue
0.6%

Earnings

Last results
October 21, 2026
Next results (est.)
February 10, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Our research
  2. Results
  3. Guidance
  4. Deal
  5. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Healthcare Services Group Inc valuation models and calculator

What the price is pricing in

The share price implies about 1.7% a year of cash-flow growth for five years.That is close to the 2.7% a year revenue growth Healthcare Services Group has delivered.

  • Priced in1.7%
  • Last 12 months4.0%
  • 3 years a year4.0%
  • 5 years a year2.7%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($25.36, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Hold12-month view
12-month price target
~$31
Price used
$25.36close November 3, 2026
Implied change
▲ +23%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of Healthcare Services Group Inc's free cash flow after stock-based pay with after-tax interest added back ($94.4M, FY2026 Q3 TTM), growing 10.6% and 6.2% in the next two years (forecasts, guidance and its record), then back to 4% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$24–~$41 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Healthcare Services Group Inc's free cash flow after stock-based pay ( $94.4M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Healthcare Services Group Inc as an operating company, with every model that fits that kind of business. Cost of equity 8.7%: the 10-year Treasury yield (4.9%) plus a beta of 0.84 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$31 ~$24–$41 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$15 ~$15–$29 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$9.5 ~$6.8–$13 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$10 ~$8.6–$12 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$20 ~$9.5–$31 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Healthcare Services Group Inc with Diversified Support Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −23%
  • Revenue growth 5 points higher ▲ +30%
  • Free-cash-flow margin 1 point lower ▼ −16%
  • Last year's free-cash-flow margin change, if it persists ▼ −33%
  • Discount rate 1 point higher ▼ −13%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $23$30$40$52$69$90
8.5% $18$23$30$39$51$66
10% $15$19$24$31$40$52

Valuation multiples over time Market data may be delayed

At fiscal year end 2016201720182019202020212022202320242025Now
Share price$32.55$44.52$34.55$21.50$25.70$16.82$12.00$10.37$11.62$19.12$25.76
Market value$2.4bn$3.3bn$2.6bn$1.6bn$1.9bn$1.3bn$892m$771m$860m$1.4bn$1.8bn
+ Net debt (− = net cash)−$24m−$10m−$26m−$27m−$139m−$71m−$1m−$29m−$57m−$125m−$135m
Enterprise value$2.4bn$3.3bn$2.6bn$1.6bn$1.8bn$1.2bn$891m$742m$803m$1.3bn$1.7bn
Multiples
Price / sales 1.5x1.8x1.3x0.9x1.1x0.8x0.5x0.5x0.5x0.8x1.0x
Price / earnings 30.9x37.5x30.9x24.8x19.5x26.0x26.1x20.1x21.8x23.6x17.3x
Price / free cash flow 66.5xn/m34.3x18.0x9.0x40.1x—20.2x35.1x10.0x17.0x
EV / EBITDA ———————————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

53 /100

Moderate moat

How hard Healthcare Services Group's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 16 / 20

    Net income has been a median 9.7% of total assets over 10 years.

  • Pricing power 8 / 20

    Gross margin has been a median 12.6%, moving by 1.7 percentage points (standard deviation) across 9 years.

  • Durability 5 / 20

    Net margin has been a median 3.8%; its worst year was 1.4%.

  • Cash conversion 11 / 20

    Free cash flow was positive in 9 of 10 years, at a median 4.0% of revenue.

  • Discipline 19 / 20

    The diluted share count fell 6.0% over five years; stock-based pay has been a median 0.5% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (58 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $1.31 +61% $1.9bn +6%
Next $1.24 −5% $2.2bn +11%

Next year's EPS estimate has moved +1.6% in 90 days, across 7 analysts.

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $0.24 $0.36 +50.9%
Jun 2026 $0.22 $0.32 +42.5%
Mar 2026 $0.22 $0.37 +72.0%
Dec 2025 $0.22 $0.44 +95.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 21, 2026
  • fourth quarter revenue fourth quarter $535m to $545m
    “The organic growth inflection we planned for, and are now delivering, sets the stage for fourth quarter revenue in the range of $535 to $545 million and low double-digit top-line growth in 2027."” source
  • full-year effective tax rate full-year about 25%
    “The Company expects its full-year effective tax rate to be approximately 25.0%.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Healthcare Services Group Inc's revenue by +10.6% next year and +6.2% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+12.0%, weight 53%) , management guidance (+15.7%, weight 20%) and the company's own record (+4.0%, weight 27%) . How the weights are set.

Analyst recommendations

7 analysts, Oct 2026
Buy457%
Hold343%
Sell00%

Monthly trend

  1. Oct 2026437
  2. Sep 2026437
  3. Aug 2026437
  4. Jul 2026336

Counts of recommendations published by analysts covering Healthcare Services Group Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
4.8%
of tradable shares
Days to cover
4.01
at average volume
Short interest, 1 month
−7%
to September 30, 2026
Held by institutions
—
of shares
Held by insiders
1.4%
of shares
Employees
36,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +44.2%

$17.87 on October 31, 2025 to $25.76

ThenNowEffect
Revenue (last 12 months) $1.8bn $1.9bn +5.2%
Net margin 0.6% 6.6% +980.8%
P/E multiple 122.0x 15.0x −87.7%
Share count 74m 71m +3.2%

Biggest factor: net margin.

Last 3 years +156.6%

$10.04 on November 3, 2023 to $25.76

ThenNowEffect
Revenue (last 12 months) $1.7bn $1.9bn +11.3%
Net margin 2.2% 6.6% +206.6%
P/E multiple 20.8x 15.0x −27.8%
Share count 74m 71m +4.1%

Biggest factor: net margin.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
HCSG−35%−29%−14%+12%+65%+35%
Industry peers (median)+4%−9%+11%+1%−10%−17%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
HCSG50%50%50%42%58%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
HCSG−50%−38%−43%−24%−21%−20%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 81% from January 26, 2018 to October 25, 2023. Getting back needed a 427% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$17.02 – $25.76
From 52-week high
0.0%
vs 50-day average
+16.9%
vs 200-day average
+20.2%
Volatility (1 year)
42%
Beta vs S&P 500
0.62

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
9 up, 3 down
typical move ±13.6%
After a week
8 up, 4 down
typical move ±12.7%
After a month
8 up, 3 down
typical move ±13.3%
Results releasedNext dayS&P 500 next day5 days21 days
October 21, 2026 +15.3% −0.7% +11.9% —
July 22, 2026 −9.6% −1.3% −5.5% −7.3%
April 22, 2026 +11.4% +0.6% +10.2% +4.4%
February 11, 2026 +10.9% −1.6% +5.1% +1.6%
October 22, 2025 +12.3% +0.1% +13.5% +4.5%
July 23, 2025 +4.5% +0.9% +2.5% +16.6%
April 23, 2025 +43.7% +3.7% +51.0% +51.8%
February 12, 2025 +3.7% +0.7% −1.2% +0.1%
October 23, 2024 +4.0% −0.7% +7.4% +12.0%
July 24, 2024 −9.1% −2.8% −3.7% −11.1%
April 24, 2024 −7.9% −0.4% −11.0% −8.8%
February 14, 2024 +31.3% +1.6% +29.0% +27.9%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Healthcare Services Group Inc’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: fundamentals grade C+ (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Healthcare Services Group Inc in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Healthcare Services Group Inc
$1.6B $1.7B $1.8B $1.9B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $1.7B Revenue (TTM), FY24 Q1: $1.7B Revenue (TTM), FY24 Q2: $1.7B Revenue (TTM), FY24 Q3: $1.7B Revenue (TTM), FY24 Q4: $1.7B Revenue (TTM), FY25 Q1: $1.7B Revenue (TTM), FY25 Q2: $1.8B Revenue (TTM), FY25 Q3: $1.8B Revenue (TTM), FY25 Q4: $1.8B Revenue (TTM), FY26 Q1: $1.9B Revenue (TTM), FY26 Q2: $1.9B Revenue (TTM), FY26 Q3: $1.9B $1.9B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $1.7B
FY24 Q1 $1.7B
FY24 Q2 $1.7B
FY24 Q3 $1.7B
FY24 Q4 $1.7B
FY25 Q1 $1.7B
FY25 Q2 $1.8B
FY25 Q3 $1.8B
FY25 Q4 $1.8B
FY26 Q1 $1.9B
FY26 Q2 $1.9B
FY26 Q3 $1.9B
Revenue growth, TTM YoY Healthcare Services Group Inc
-5% 0% 5% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -1.1% Revenue growth, TTM YoY, FY24 Q1: -0.2% Revenue growth, TTM YoY, FY24 Q2: 0.6% Revenue growth, TTM YoY, FY24 Q3: 1.8% Revenue growth, TTM YoY, FY24 Q4: 2.7% Revenue growth, TTM YoY, FY25 Q1: 3.7% Revenue growth, TTM YoY, FY25 Q2: 5.2% Revenue growth, TTM YoY, FY25 Q3: 6.3% Revenue growth, TTM YoY, FY25 Q4: 7.1% Revenue growth, TTM YoY, FY26 Q1: 6.5% Revenue growth, TTM YoY, FY26 Q2: 5.2% Revenue growth, TTM YoY, FY26 Q3: 4.0% 4.0%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -1.1%
FY24 Q1 -0.2%
FY24 Q2 0.6%
FY24 Q3 1.8%
FY24 Q4 2.7%
FY25 Q1 3.7%
FY25 Q2 5.2%
FY25 Q3 6.3%
FY25 Q4 7.1%
FY26 Q1 6.5%
FY26 Q2 5.2%
FY26 Q3 4.0%
FCF margin (TTM) Healthcare Services Group Inc
0% 5% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 2.3% FCF margin (TTM), FY24 Q1: 1.6% FCF margin (TTM), FY24 Q2: 2.1% FCF margin (TTM), FY24 Q3: 2.2% FCF margin (TTM), FY24 Q4: 1.4% FCF margin (TTM), FY25 Q1: 4.5% FCF margin (TTM), FY25 Q2: 5.1% FCF margin (TTM), FY25 Q3: 8.7% FCF margin (TTM), FY25 Q4: 7.6% FCF margin (TTM), FY26 Q1: 8.4% FCF margin (TTM), FY26 Q2: 8.0% FCF margin (TTM), FY26 Q3: 5.7% 5.7%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 2.3%
FY24 Q1 1.6%
FY24 Q2 2.1%
FY24 Q3 2.2%
FY24 Q4 1.4%
FY25 Q1 4.5%
FY25 Q2 5.1%
FY25 Q3 8.7%
FY25 Q4 7.6%
FY26 Q1 8.4%
FY26 Q2 8.0%
FY26 Q3 5.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 1,563 1,861 2,003 1,841 1,760 1,642 1,690 1,671 1,716 1,837 1,880
Gross profit 223 251 234 228 268 231 193 215 228 239 303
Net income 77 88 84 65 99 49 34 38 39 59 105
Diluted EPS $1.05 $1.19 $1.12 $0.87 $1.32 $0.65 $0.46 $0.52 $0.53 $0.81 $1.49
Growth (year on year)
Revenue — +19.1% +7.6% −8.1% −4.4% −6.7% +2.9% −1.1% +2.7% +7.1% +4.0%
Net income — +14.0% −5.3% −22.7% +52.8% −50.8% −29.5% +12.1% +2.8% +49.6% +163.9%
Diluted EPS — +13.3% −5.9% −22.3% +51.7% −50.8% −29.2% +13.0% +1.9% +52.8% +175.0%
Margins
Gross margin 14.3% 13.5% 11.7% 12.4% 15.2% 14.0% 11.4% 12.8% 13.3% 13.0% 16.1%
Net margin 5.0% 4.7% 4.2% 3.5% 5.6% 3.0% 2.0% 2.3% 2.3% 3.2% 5.6%
Free-cash-flow margin 2.3% 0.1% 3.7% 4.8% 12.1% 1.9% −0.8% 2.3% 1.4% 7.6% 5.7%
Cash flow
Cash from operations 41 8 80 94 217 37 −8 43 31 145 113
Capital spending 5 5 5 4 4 6 5 5 6 6 6
Free cash flow 36 2 75 89 213 31 −13 38 24 139 107
Stock-based pay 4 6 6 7 8 9 9 9 9 12 11
Free cash flow after stock pay 32 −4 69 82 205 23 −23 29 15 127 95
Balance sheet
Cash 24 10 26 27 139 71 26 54 57 125 135
Total debt 0 0 0 0 0 0 25 25 0 0 0
Net debt (negative = net cash) −24 −10 −26 −27 −139 −71 −1 −29 −57 −125 −135
Diluted shares 73m 74m 75m 75m 75m 75m 74m 74m 74m 73m 71m
Returned to shareholders
Dividends 53 55 57 59 61 62 63 0 0 — —
Buybacks — — — 0 0 22 0 11 5 62 76
Total returned 53 55 57 59 61 84 63 11 5 62 76

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 1 checks passed · September 30, 2026
What it owns · $850m
Short-term assets $583mLonger-term assets $268m
What it owes, and who funded it · $738m
Short-term liabilities $206mShareholders' equity $531m
  • Short-term assets cover short-term liabilities $583m of assets due within a year against $206m of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Healthcare Services Group Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$76.2M
Buybacks, last 3 fiscal years
$77.9M
Diluted share count
−4.0%
year over year
Total shareholder yield
4.4%
dividends 0.0% + buybacks 4.4% of market value
Sales & admin spending
10.1%
of revenue
Days sales outstanding
60 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in diversified support services
Last 12 months unless stated HCSG OPLN WSC CXW UNF VSTS Median
Revenue, last 12 months $1.9bn $2.1bn $2.3bn $2.5bn $2.5bn $2.7bn $906m
Revenue growth, last 12 months 4.0% 11.8% −2.5% 24.3% 3.7% −0.4% 6.3%
Revenue growth, 3-year average 4.0% 8.4% −0.3% 10.2% 4.2% — 6.4%
Revenue growth, latest quarter 3.3% 15.1% 3.9% 27.3% 5.0% −1.8% 7.2%
Gross margin 16.1% — 50.5% — 36.6% — 29.0%
Operating margin — 11.5% 6.5% 5.9% 5.4% 3.6% 4.9%
Operating margin, 3-year average — 10.1% 14.3% 11.1% 6.8% 4.3% 9.9%
Net margin 5.6% 9.7% −3.0% 5.1% 4.3% −0.2% 2.7%
Cash from operations / revenue 6.0% 19.8% 30.7% 8.1% 8.1% 7.1% 7.1%
Free-cash-flow margin 5.7% 17.1% 29.7% 2.4% 2.8% 5.1% 3.7%
Free-cash-flow margin, 3-year average 5.5% 14.5% 28.7% 6.5% 4.7% 7.4% 7.4%
Stock pay / revenue 0.6% 1.3% 1.6% 1.1% 0.5% 0.4% 1.4%
Change in share count −4.0% −0.1% −3.1% −7.1% −2.1% 0.6% 0.1%

Median of all 32 companies we cover in diversified support services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

32 diversified support services companies
Measure Company Peer median Rank
Revenue growth Growth 4.0% 6.5% 22 of 32
Change in growth rate Growth -1.3pp +0.8pp 22 of 32
Gross margin Profitability 16.1% 26.4% 14 of 22
Net margin Profitability 5.6% 3.3% 11 of 32
Free-cash-flow margin Cash generation 5.7% 4.1% 14 of 31
Stock pay as % of revenue Cash generation 0.6% 1.4% 6 of 26
Change in share count Balance sheet -4.0% -0.1% 7 of 28
Days sales outstanding Balance sheet 60 days 60 days 14 of 26

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Dietary Services $1B 55.1% ▲ 6.5%
Environmental Services $825M 44.9% ▲ 7.7%

From Healthcare Services Group Inc's 10-K filed February 13, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$1.8B
Institutions reporting
274
Shares held vs prior quarter
▲ 0.4%
Positions opened / closed
45 / 30

Top buyers and sellers, Q2 2026: 137 institutions bought and 133 sold ; the biggest buyer was Pembroke Management, Ltd (+747K shares) and the biggest seller Mackenzie Financial Corp (−1.8M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $279M 11.4M 15.7% ▼ 0.7%
Vanguard Portfolio Management LLC $125M 5.1M 7.0% ▲ 4.8%
Vanguard Capital Management LLC $74.7M 3.0M 4.2% ▼ 2.5%
State Street Corp $71.6M 2.9M 4.0% ▲ 3.4%
American Century Companies Inc $65.4M 2.7M 3.7% ▲ 6.1%
Geode Capital Management, LLC $62.9M 2.6M 3.5% ▲ 25.3%
Dimensional Fund Advisors LP $61M 2.5M 3.4% ▲ 3.5%
FMR LLC $56.4M 2.3M 3.2% ▲ 16.8%
Ameriprise Financial Inc $55.4M 2.3M 3.1% ▲ 4.1%
Royce & Associates LP $55M 2.2M 3.1% ▲ 4.5%
Arrowstreet Capital, Limited Partnership $35.4M 1.4M 2.0% ▲ 2.6%
Franklin Resources Inc $30.6M 1.2M 1.7% ▲ 7.2%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Healthcare Services Group Inc's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $3.8M 8 trades by 5 insiders · 1% under pre-set plans
Net ▼ $3.8M net selling
Insider Date Trade Shares Price Value
Bundick Jason J EVP/Gen. Counsel/Corp. Secty. October 26, 2026 Sell 18,239 $25.11 $457,981
Kush Andrew EVP & Chief Operating Officer August 4, 2026 Sell 15,598 $23.24 $362,498
Brophy Andrew M SVP & Chief Accounting Officer February 26, 2026 Sell pre-set plan 2,490 $21.75 $54,158
Shea John Christopher EVP & Chief Admin. Officer February 18, 2026 Sell 38,857 $20.36 $791,129
Shea John Christopher EVP & Chief Admin. Officer February 18, 2026 Sell 15,500 $20.52 $318,060
Orr Patrick J EVP & Chief Revenue Officer February 18, 2026 Sell 45,500 $20.54 $934,570
Orr Patrick J EVP & Chief Revenue Officer February 18, 2026 Sell 33,448 $20.52 $686,353
Orr Patrick J EVP & Chief Revenue Officer February 18, 2026 Sell 11,167 $20.55 $229,482

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 11 trades and filings

No trades in Healthcare Services Group Inc disclosed in the last 12 months; 11 earlier trades on record.

  • Greg Gianforte(MT):Purchase, $50,001 - $100,000, traded April 30, 2020, filed May 7, 2020
  • Greg Gianforte(MT):Purchase, $100,001 - $250,000, traded October 11, 2019, filed November 27, 2019
  • Greg Gianforte(MT):Sale (full), $100,001 - $250,000, traded September 10, 2019, filed October 20, 2019

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around February 10, 2027 estimated from the company's past filing pattern, not announced

  • October 21, 2026
  • July 22, 2026
  • April 22, 2026
  • February 11, 2026
  • October 22, 2025
  • July 23, 2025

Recent SEC filings

Data status

When each part of this page on Healthcare Services Group Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Healthcare Services Group Inc in brief

What does Healthcare Services Group Inc do?
Healthcare Services Group Inc is a US-listed company in the diversified support services industry. Its financial year ends in December.
What is Healthcare Services Group Inc's stock ticker?
Healthcare Services Group Inc trades under the ticker HCSG on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Healthcare Services Group Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Healthcare Services Group Inc reported revenue of $1.9B, 4.0% higher than a year earlier, according to its SEC filings.
What is Healthcare Services Group Inc's free cash flow?
Healthcare Services Group Inc's free-cash-flow margin is 5.7% of revenue over the trailing twelve months, ranking 14 of the 31 diversified support services companies we cover.
What is Healthcare Services Group Inc's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Healthcare Services Group Inc's free cash flow after stock-based pay gives ~$31 per share in the base case, and ~$24–$41 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Healthcare Services Group Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Portfolio Management LLC and Vanguard Capital Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Healthcare Services Group Inc buying back stock, and does it pay a dividend?
Healthcare Services Group Inc spent $76.2M on share repurchases over the trailing twelve months, and its diluted share count fell 4.0% over the year.
What is Healthcare Services Group Inc's market cap?
On November 2, 2026, Healthcare Services Group Inc's market capitalisation was about $1.8B, with a price-to-earnings ratio of 17.3 and net debt of -$135M. Market figures come from third-party market data and may be delayed.
Who are Healthcare Services Group Inc's competitors?
In our Diversified Support Services peer group, the companies closest to Healthcare Services Group Inc are Openlane, Inc., Willscot Holdings Corp, Corecivic, Inc., Unifirst Corp and Vestis Corp. The side-by-side comparison below sets their revenue, margins and growth against Healthcare Services Group Inc's.
Are insiders buying or selling Healthcare Services Group Inc stock?
Over the last 12 months, Healthcare Services Group Inc's directors and officers reported 0 open-market purchases and 8 sales on Form 4. The insider trading page charts every trade.
When is Healthcare Services Group Inc's next earnings date?
Around February 10, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Healthcare Services Group Inc announces its own schedule.